Company
Brenus Pharma
Bring the immune system one step ahead of cancer
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Clermont-Ferrand, France
- Legal name
- Brenus Pharma
Claim, correct or request removal
Record updated 28 September 2026
About
Off-the-shelf platform advancing next-generation in vivo immunotherapies to unlock immune response against solid tumors
Funding snapshot
- Total raised
- $25MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A2026-07-21
Funding rounds
- Series A
- 2026-07-21
- Round, 2024
- $25M2024-09-18, Company stated
- Grant
- 2024-01-22
Products
- Other
- STC-1010
Loading relationship preview